Ramiprilat attenuates hypoxia/reoxygenation injury to cardiac myocytes via a bradykinin-dependent mechanism

European Journal of Pharmacology

Volumn 306, Issue 1-3, 1996, Pages 165-174

  Wall, Theron M ^a   Linseman, Daniel A ^a   Hartman, J Craig ^a  

^a PFIZER INC   (United States)

Author keywords

angiotensin converting enzyme inhibitor; bradykinin; bradykinin B2 receptor antagonism; cardiac myocytre; HOE 140 (H D Arg Arg Pro Hyp Gly Thi Ser D Tic Oic Arg OH); hypoxia reoxygenation injury; ramiprilat

Indexed keywords

BRADYKININ; BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUORESCENT DYE; ICATIBANT; PROPIDIUM IODIDE; RAMIPRILAT;

ANIMAL CELL; ARTICLE; CELL DAMAGE; CELL PROTECTION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG MECHANISM; FLUORESCENCE; HEART MUSCLE CELL; HEART MUSCLE FIBER MEMBRANE; HYPOXIA; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT; REOXYGENATION;

EID: 0030582097     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00030-1     Document Type: Article

References (42)

1. Armstrong, S., J.M. Downey and C.E. Ganote, 1994, Preconditioning of isolated rabbit cardiomyocytes: induction by metabolic stress and blockade by the adenosine antagonist SPT and calphostin C, a protein kinase C inhibitor, Cardiovasc. Res. 28, 72.
2. Balligand, J.L., D. Ungureanu, R.A. Kelly, L. Kobzik, D. Pimental, T. Michel and T.W. Smith, 1993, Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium, J. Clin. Invest. 91, 2314.
3. Balligand, J.L., L. Kobzik, X. Han, D.M. Kaye, L. Belhassen, D.S. O'Hara, R.A. Kelly, T.W. Smith and T. Michel, 1995, Nitric oxide-dependent parasympathetic signaling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes, J. Biolog. Chem. 270 (24), 14582.
4. Baumgarten, C.R., W. Linz, G. Kunkel, B.A. Schölkens and G. Wiemer, 1993, Ramiprilat increases bradykinin outflow from isolated hearts of rat, Br. J. Pharmacol. 108, 293.
5. Bhoola, K.D., C.D. Figueroa and K. Worthy, 1992, Bioregulation of kinins: kallikreins, kininogens and kininases, Pharmacol. Rev. 44.1.
6. 2 activation, platelet-activating factor generation and prostacyclin release in spontaneously beating rat cardiomyocytes, Biochem. J. 290, 477.
7. De Mello, W.C., M.J. Crespo and P.I. Altieri, 1992, Enalapril increases cardiac refractoriness, J. Cardiovasc. Pharmacol. 20, 820.
8. Dostal, D.E., K.N. Rothblum, K.M. Conrad, G.R. Cooper and K.M. Baker, 1992, Detection of angiotensin I and II in cultured rat cardiac myocytes and fibroblasts. Am. J. Physiol. 263 (Cell Physiol. 32), C851.
9. Dzau V.J. and R.N. Re, 1987, Evidence for the existence of renin in the heart, Circulation 75 (Suppl. I), I-134.
10. Freshney, R.I., 1987, Quantitation and experimental design, in: Culture of Animal Cells: A Manual of Basic Technique, 2nd edn. (Wiley-Liss, New York) p. 227.
11. Grover, G.J., S. Dzwonczyk, C.S. Parham and P.C. Sleph, 1990, The protective effects of cromakalim and pinacidil on reperfusion function and infarct size in isolated perfused rat hearts and anesthetized dogs, Cardiovasc. Drugs Ther. 4, 465.
12. Grover, G.J., P.G. Sleph, S. Dzwonczyk, P. Wang, W. Fung, D. Tobias and D.W. Cushman, 1991, Effects of different angiotesin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection, J. Pharmacol. Exp. Ther. 257 (3), 919.
13. Hall, J.M., 1992, Bradykinin receptors: pharmacological properties and biological roles, Pharmacol. Ther. 56, 131.
14. Hartman, J.C., T.M. Wall, T.G. Hullinger and R.J. Shebuski, 1993a, Reduction of myocardial infarct size in rabbits by ramiprilat: reversal by the bradykinin antagonist HOE 140, J. Cardiovas. Pharmacol. 21, 996.
15. Hartman, J.C., T.G. Hullinger, T.M. Wall and R.J. Shebuski, 1993b, Reduction of myocardial infarct size by ramiprilat is independent of angiotensin II synthesis inhibition, Eur. J. Pharmacol. 234, 229.
16. Hartman, J.C., G.M. Kurc, T.G. Hullinger, T.M. Wall, R.M. Sheehy and R.J. Shebuski, 1994, Inhibition of nitric oxide synthase prevents myocardial protection by ramiprilat, J. Pharmacol. Exp. Ther. 270, 1071.
17. Hial, V., M.A. Gimbrone, M.P. Peyton, C.M. Wilcox and J.J. Pisano, 1979, Angiotensin metabolism by cultured human vascular endothelial and smooth muscle cells, Microvasc. Res. 17, 314.
18. + currents in a neuronal cell, Nature 323, 333.
19. Jackson, W.F., A. König, T. Dambacher and R. Busse, 1993, Prostacyclin-induced vasodilation in rabbit heart is mediated by ATP-sensitive potassium channels, Am. J. Physiol. 264 (Heart Circ. Physiol. 33), H238.
20. Kasten, F.H., 1973, Mammalian myocardial cells, in: Tissue Culture Methods and Applications, ed. P.F. Kruse and M.K. Patterson (Academic Press, New York and London) p. 72.
21. 2+ and mitochondrial membrane potential preceding cell death in hepatocytes, Nature 325, 78.
22. Lindpaintner, K., M. Jin, N. Niedermaier, M.J. Wilhelm and D. Ganten, 1990, Cardiac angiotensinogen and its local activation in the isolated perfused beating heart, Circ. Res. 67, 564.
23. Linseman, D.A., T.M. Wall and J.C. Hartman, 1994, The trolox analog, U-78517F, attenuates hypoxic injury in isolated cardiac myocytes, J. Mol. Cell. Cardiol. 26, 1249.
24. Linz, W., G. Wiemer and B.A. Schölkens, 1992, ACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts, J. Mol. Cell. Cardiol. 24, 909.
25. Martorana, P.A., B. Kettenbach, G. Breipohl, W. Linz and B.A. Scholkens, 1990, Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist, Eur. J. Pharmacol. 182, 395.
26. 2 bradykinin receptor, Proc. Natl. Acad. Sci. USA 88, 7724.
27. Minshall, R.D., D.J. Miletich, S.M. Vogel, R.P. Becker, E.G. Erdos and S.F. Rabito, 1994, Existence of bradykinin (BK) binding sites in rat cardiomyocytes, Abstract, Faseb J. 8 (5), A884.
28. Moshi, M.J., I.J. Zeitlin, C.L. Wainwright and J.R. Parratt, 1992, Acid optimum kininogenases in canine myocardium and aorta, Cardiovasc. Res. 26, 367.
29. Parratt, J.R., 1994, Cardioprotection by angiotensin converting enzyme inhibitors - the experimental evidence, Cardiovasc. Res. 28, 183.
30. Pi, X. and X. Chen, 1989, Captopril and ramiprilat protect against free radical injury in isolated working rat hearts, J. Mol. Cell. Cardiol. 21, 1261.
31. Rabkin, S.W., 1993, Lisinopril increases the recovery during reoxygenation and resistance to oxidative damge in cradiomyocytes, Eur. J. Pharmacol. 238, 81.
32. Schmaier, A.H., 1992, Modulation of cell membrane expression of the kininogens regulates the rate of bradykinin delivery to cells, Trends Cardiovasc. Med. 2 (3), 108.
33. Schunkert, H., B. Jackson, S.S. Tang, F.J. Schoen, J.F.M. Smits, C.S. Apstein and B.H. Lorell, 1993, Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts, Circulation 87, 1328.
34. + channel openers, in: Klinische Pharmakologie. Clinical Pharmacology, Vol. 7, Importance of Prostacyclin and Potassium Channels for the Regulation of Vascular Tone, ed. J.C. Frölich and U. Förstermann (W. Zuckschwerdt Verlag) p. 72.
35. Thandroyen, F.T., D. Bellotto, A. Katayama, H.K. Hagler, J.T. Willerson and L.M. Buja, 1992, Subcellular electrolyte alterations during progressive hypoxia following reoxygenation in isolated neonatal rat ventricular myocytes, Circ. Res. 71, 106.
36. Tian, R., S. Neubauer, F. Pulzer, U. Haas and G. Ertl, 1991, Angiotensin I conversion and coronary constriction by angiotensin II in ischemic and hypoxic isolated rat hearts, Eur. J. Pharmacol. 203, 71.
37. Toombs, C.F., N.R. Norman, V.E. Groppi, K.S. Lee, R.C. Gadwood and R.J. Shebuski, 1992, Limitation of myocardial injury with the potassium channel opener cromakalim and the nonvasoactive analog U-89,232: vascular vs. cardiac actions in vitro and in vivo, J. Pharmacol. Exp. Ther. 263 (3), 1261.
38. Van Gilst, W.H., P.A. De Graeff, H. Wesseling and C.D.J. De Langen, 1986, Reduction of reperfusion arrhythmias in the ischemic isolated rat heart by angiotensin converting enzyme inhibitors: a comparison of captopril, enalapril, and HOE 498, J. Cardovasc. Pharmacol. 8, 722.
39. Westlin, W. and K. Mullane, 1988, Does caprtopril attenuate reperfusion-induced myocardial dysfunction by scavenging free radicals?, Circulation 77 (Suppl. I), I-30.
40. Wiemer, G., B.A. Schölkens, R.H.A. Becker and R. Busse, 1991, Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin, Hypertension 18, 558.
41. Yongge, L., K. Ytrehus and J.M. Downey, 1994, Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium, J. Mol. Cell. Cardiol. 26, 661.
42. Zanzinger, J.X. Zheng and E. Bassenge, 1994, Endothelium dependent vasomotor responses to endogenous agonists are potentiated following ACE inhibition by a bradykinin dependent mechanism, Cardiovasc. Res. 28, 209.